226 related articles for article (PubMed ID: 25010649)
1. Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease.
Alix PM; Guebre-Egziabher F; Soulage CO
Biochimie; 2014 Oct; 105():12-21. PubMed ID: 25010649
[TBL] [Abstract][Full Text] [Related]
2. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney.
Nasrallah MP; Ziyadeh FN
Semin Nephrol; 2013 Jan; 33(1):54-65. PubMed ID: 23374894
[TBL] [Abstract][Full Text] [Related]
3. Adipokines as uremic toxins.
Teta D
J Ren Nutr; 2012 Jan; 22(1):81-5. PubMed ID: 22200420
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin and leptin pathophysiology in chronic kidney disease.
Gunta SS; Mak RH
Pediatr Nephrol; 2013 Apr; 28(4):611-6. PubMed ID: 23229444
[TBL] [Abstract][Full Text] [Related]
5. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
[TBL] [Abstract][Full Text] [Related]
6. The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients.
Korczynska J; Czumaj A; Chmielewski M; Swierczynski J; Sledzinski T
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925217
[TBL] [Abstract][Full Text] [Related]
7. The kidney and uremic toxin removal: glomerulus or tubule?
Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".
Castillo-Rodríguez E; Pizarro-Sánchez S; Sanz AB; Ramos AM; Sanchez-Niño MD; Martin-Cleary C; Fernandez-Fernandez B; Ortiz A
Toxins (Basel); 2017 Mar; 9(4):. PubMed ID: 28333114
[TBL] [Abstract][Full Text] [Related]
9. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Black AP; Cardozo LF; Mafra D
Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
[TBL] [Abstract][Full Text] [Related]
10. Leptin and chronic kidney diseases.
Mao S; Fang L; Liu F; Jiang S; Wu L; Zhang J
J Recept Signal Transduct Res; 2018 Apr; 38(2):89-94. PubMed ID: 29388492
[TBL] [Abstract][Full Text] [Related]
11. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients.
Guebre-Egziabher F; Debard C; Drai J; Denis L; Pesenti S; Bienvenu J; Vidal H; Laville M; Fouque D
Nutrition; 2013 May; 29(5):730-6. PubMed ID: 23375525
[TBL] [Abstract][Full Text] [Related]
12. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
Mallamaci F; Tripepi G; Zoccali C
J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
[TBL] [Abstract][Full Text] [Related]
13. Disposition and clinical implications of protein-bound uremic toxins.
Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
[TBL] [Abstract][Full Text] [Related]
14. Review article: The role of adipose tissue in uraemia-related insulin resistance.
Manolescu B; Stoian I; Atanasiu V; Busu C; Lupescu O
Nephrology (Carlton); 2008 Oct; 13(7):622-8. PubMed ID: 18826486
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis.
Mak RH; Cheung WW; Solomon G; Gertler A
Curr Pharm Des; 2018; 24(9):1012-1018. PubMed ID: 29366406
[TBL] [Abstract][Full Text] [Related]
16. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
17. The role of leptin and its short-form receptor in inflammation in db/db mice infused with peritoneal dialysis fluid.
Leung JC; Chan LY; Lam MF; Tang SC; Chow CW; Lim AI; Lai KN
Nephrol Dial Transplant; 2012 Aug; 27(8):3119-29. PubMed ID: 22287654
[TBL] [Abstract][Full Text] [Related]
18. Role of fat mass and adipokines in chronic kidney disease.
Axelsson J; Stenvinkel P
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):25-31. PubMed ID: 18090666
[TBL] [Abstract][Full Text] [Related]
19. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
20. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
Fujii H; Goto S; Fukagawa M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
